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LETTERS TO THE EDITOR
Redefinition of Myocardial
Infarction by a Consensus Dissenter
Collaboration between the European Society of Cardiology (ESC)
and the American College of Cardiology (ACC) is praiseworthy
(1), but the joint attempt (2) to supplant the current World Health
Organization (WHO) definition of myocardial infarction (3) is
flawed in process and in outcome. The new definition (2), a
manifesto for measurement of troponins, cannot work for many of
the purposes for which a revised definition is needed. The two
cardiological organizations should recognize that they have not
succeeded, study what went wrong and cooperate with the indi-
viduals and organizations who can ensure that the job is com-
pleted.
Diagnosis of coronary events, including myocardial infarction,
has always been dependent on the availability, frequency and
timing of corroborative tests—electrocardiographic or serologic—
the potential curtailment or censoring of these by death and the
almost arbitrary availability/nonavailability of documentation and
autopsy findings in fatal cases (3–5). In nonfatal cases, the
distinction between acute and subacute or chronic, is difficult. The
syndromes resemble a comet in which the front of the head is
distinct but the beginning and end of the tail are not—the
cut-points are arbitrary but determine relative proportions. In fatal
cases, in which pathological findings are available, delayed deaths
may show established infarction but no coronary thrombus, while
early deaths may show the opposite, or indeed, no obvious acute
event. Definition implies a rigid classification, and not, as many
clinicians imagine, description of a subset of idealized cases.
After 30 years of defining, refining, coding and classifying
coronary events and ensuring quality control (6–9), I had recently
urged that the 20-year-old definitions of coronary events, drafted
with others for the WHO MONitoring of trends and determi-
nants in CArdiovascular disease (MONICA) Project in 1981 (3),
be updated (10). I welcomed the ESC/ACC initiative and was
nominated as their representative by the ESC Working Group on
Epidemiology and Prevention, which includes a large number of
MONICA investigators, charging me to keep them appraised of
progress. I participated in the consensus meeting, co-chaired the
epidemiology group, presented its written recommendations on
the final day, and received some “notes” of the different group
recommendations in September 1999, but nothing further. Previ-
ously assured that the July 1999 meeting was the first of a series of
meetings and consultations, none has involved me. Despite use of
my name, I never saw the new consensus definition for comment
or approval until after it was published. I am in good company.
What happened raises two issues in accountability to the
medical profession, and to the wider public interest, before
consideration of the definition itself. The “consensus” committee
was heterogeneous and there could be no suspicion of commercial
influence. That cannot be said of a document of opaque prove-
nance, giving a virtual monopoly to assays subject to commercial
patents. The lack of a true consensus process makes the two
colleges and two journals appear negligent in not asking for details
of consultancies and shareholdings by those involved. Although
the issue is almost certainly irrelevant, it cannot explicitly be seen
to be so. There is no clear audit trail as to how these criteria were
derived and approved. Due process would have ensured transpar-
ency. Senior committees asked to endorse a “consensus” will be less
careful and critical than when confronted with known partisan
opinions.
The public interest is also involved in the alleged “consensus”
recommendation that microscopic muscle necrosis, sufficient to
produce a measurable blood troponin “blip,” should automatically
attract the label of “myocardial infarction.” If the word “consensus”
means “majority,” then this was true on a show of hands of the
picked participants, but this was not overwhelming. A vociferous
minority, including some workshop groups, argued against the
proposal. It has immense consequences for potential public mis-
understanding, “labeling,” employment and insurance. Interven-
tional cardiologists and cardiac surgeons will not be pleased to have
to tell postoperative patients with a trivial rise in troponin levels
that they had a myocardial infarction. This question is not solely of
concern to cardiologists, but should involve consulting those
responsible for rehabilitation, health promotion, employment and
insurance and for paying medical costs, before a final decision is
made. The epidemiology group preferred the term “myocardial
injury” for events involving only minor damage.
The “definition” itself is flawed in two respects. It is not
comprehensive for living cases and it virtually ignores fatal ones.
The new definition gives a key role to an observed “rise and fall” in
biochemical markers (2). In many case series, about 20% of cases
of myocardial infarction take .24 h to come under care (8), by
which time it would be too late to observe a rise. Cases with a “rise”
would have to survive under care for several days in order to
guarantee a “fall.” So an ESC/ACC “myocardial infarction” is a
case coming under care very early in the attack that has repeated
troponin tests over many days, and is inherently unlikely to
succumb for that reason alone (2,5). Other cases are excluded by
this definition. What about the general practitioner’s case admitted
to a cottage hospital who shows classic electrocardiographic
progression but whose blood samples get lost in transit to the
laboratory? Unequivocal electrocardiographic progression, without
the need for serological confirmation, has always been accepted as
diagnostic by clinicians (and by WHO criteria, seriously mis-
quoted in this document) (3,4). What about the patient who dies
on arrival to the coronary care unit?
The squeamishness of Dr. Alpert’s and Dr. Thygesen’s defini-
tion concerning fatal cases creates immense problems for the utility
of these criteria. Epidemiologists are made of stronger stuff (3,4).
There is a need for diagnostic criteria and definitions that can be
used generally, not only by epidemiologists but also in the modern
enthusiasm for league tables and performance indicators, beloved
of health service administrators. You cannot have criteria covering
nonfatal cases alone. Imagine two hospitals following identical
criteria for nonfatal cases, but applying their own arbitrary criteria
for what is a fatal case. Their statistics would be given false
respectability by the standardization of nonfatal criteria, but their
reported fatality rates could appear to be very different, when in
reality they were exactly the same. Not all fatal cases show
demonstrable myocardial infarctions, which is why MONICA
calls heart attacks coronary events, and fatal events coronary
deaths.
The new criteria may be suitable for recruiting coronary care
unit survivors into clinical trials: one apparent rationale (2). They
are unusable for general diagnostic use. They are not incorporated
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into a diagnostic classification which is comprehensive. They do
not cover early and other fatal cases, and nonfatal cases in which
tests are partial, delayed, missing or curtailed. Therefore, they are
not applicable to more than a proportion of coronary events in the
real world. New criteria need to be field tested and related either to
the current, or a modified version, of the International Statistical
Classification of Diseases and Health Problems (11) before they
are adopted, or there will be diagnostic confusion and chaos in
hospital and regional morbidity statistics. Comparative figures
could reflect the frequency and intensity of troponin measurement,
rather than the underlying disease burden.
None of this denies the immense value of the newer biochemical
markers such as troponins (12) in increasing the sensitivity and
specificity of diagnosis of coronary events; nor the consequent need
for older definitions and classifications to be revised for the modern
era, and for the purposes specified by the college presidents in their
accompanying editorial (1). The WHO MONICA Project criteria
were drafted 20 years ago (3) with strong transatlantic collabora-
tion to marry older European qualitative criteria (4), for classifying
myocardial infarction and coronary deaths, with American preci-
sion. These criteria mapped trends in coronary disease incidence
and case fatality across four continents for over a decade, in a third
of a million cases (9). It is time they were updated by those with
expertise in the field. The names of epidemiologists involved in
this recent “consensus” exercise have been used, while they them-
selves have been kept at arm’s length. Diagnosis means more than
recruitment to clinical trials. We are discussing among ourselves
how to carry the need for revised criteria forward from this brave
but flawed attempt. We hope to have the help of national and
international organizations.
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REPLY
We would like to thank Dr. Tunstall-Pedoe for his comments.
Controversy is the soul of all intellectual activities, and we welcome
Dr. Tunstall-Pedoe’s minority opinion concerning the recently
published consensus statement on the definition of myocardial
infarction. Unfortunately, Dr. Tunstall-Pedoe has seriously mis-
understood and misinterpreted both the nature of the European
Society of Cardiology/American College of Cardiology (ESC/
ACC) conference and the published document.
Dr. Tunstall-Pedoe was invited to participate in the meeting to
provide context for our discussions given his many years of
involvement with the original and subsequent modified World
Health Organization (WHO) definitions of myocardial infarction.
The conference was conceived as a joint project of the ESC and the
ACC with the hope that it would help to standardize the
definition of myocardial infarction in clinical studies, patient care
and health care statistics.
Procedure followed. The original participants at the first meeting
at the European Heart House created a first draft of the document.
Because of the large number of individuals involved (50) at this
first conference, a smaller number (6) were selected for further
work on the manuscript and its eventual report. It was never our
expectation that everyone in the medical community nor even
everyone at the original conference would be in total agreement
with the final report. We sought, therefore, to create a document
that would be accepted by most clinicians, investigators and
epidemiologists.
A first draft was sent to all participants, including Dr. Tunstall-
Pedoe. Anyone who responded to the first draft was sent subse-
quent drafts. Indeed, anyone who requested the then current draft
of the document received it by e-mail. The report went through 13
versions before the document was published. Dr. Tunstall-Pedoe
did not respond to the first draft that contained approximately 70%
of the material that was eventually published. Three other recog-
nized and widely published epidemiologists received all subsequent
drafts of the document and all their suggestions were incorporated
into the published report. The final manuscript was read and
critiqued by the Scientific and Clinical Initiative Committee of the
ESC, the Board of the ESC, selected leaders of the ACC and
selected reviewers.
Dr. Tunstall-Pedoe suggests that we should have sought input
from interest groups involved with rehabilitation, health promo-
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